Search reports.
USA Artificial Organs and Bionic Implants Market | 2031
Get free sample report Request for Customiztion Buy Now

USA Artificial Organs and Bionic Implants Market | 2031

Segments - USA Artificial Organs and Bionic Implants Market by Products (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, and Others]), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1817 | 4.8 Rating | 83 Reviews | 187 Pages | Format : PDF Excel PPT

Report Description


USA Artificial Organs and Bionic Implants Market Outlook 2031:

The USA Artificial Organs and Bionic Implants Market size was valued at USD 8.61 Billion in 2022 and is projected to reach USD 15.84 Billion by 2031, expanding at a CAGR of 7.01% during the forecast period 2023 - 2031. The growth of the market is attributed to increasing demand for artificial limbs. Moreover, increasing healthcare expenditure in the country is expected to drive the market growth.

Artificial organs are made by medical professionals and are deployed in human bodies with living tissue. It performs the original function of human body parts. Artificial organs are used to replace the functions of a faulty or missing organ or other part of the human body.

USA Artificial Organs and Bionic Implants Market Outlook

Some of these organs include artificial heart and pacemaker. Bionics refers to the replacement or improvement of body parts by use of mechanical or electronic parts. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person. Bionics merges biology, mechanics, engineering, and computer science to create realistic and functional parts of the body.

The major applications of bionics are arms, legs and hearing aids. Conversely, the strides are being made in areas such as organs, vision and brain. The bionics industry has grown around four major application areas, which are vision, hearing, orthopedics and a small, motley group of implants that augment cardiac and neurological functions.

  • Increasing incidence of disabilities and organ failures in geriatric patients is one of the major drivers that is contributing to the growth of the USA Artificial Organs and Bionic Implants Market.
  • Rising technological advancements, leading to enhanced applications of various implants and artificial organs is expected to augment the market growth.
  • The Covid-19 pandemic has impacted the artificial organ bionic implant market owing to the disruption in the supply chain. However, the market is anticipated to recover soon.
  • Fear of device malfunction and infection can restrain the growth of the market.
  • Limited specialists to carry out the procedure in the artificial organic and bionic implant segment in turn can hinder the market growth.
  • Growing number of grants to fund the research and development in the field of artificial organs and bionics is expected to create lucrative opportunities in the projected timeline.
  • Ongoing technological advancements is expected to create lucrative opportunities during the forecast period.

Scope of Artificial Organs and Bionic Implants Market Report

The report on the USA Artificial Organs and Bionic Implants Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

USA Artificial Organs and Bionic Implants Market -  Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants,  and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, Others])

Geographical Zone

US

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

ABIOMED, Boston Scientific Corporation, Berlin Heart GmbH, Edward Lifesciences Corporation, Otto Bock Holding GmbH & Co. KG, LifeNet Health and Medtronic plc.

USA Artificial Organs and Bionic Implants Market Segment Insights

Bionics segment to grow at a rapid pace

Based on products, the market is divided into artificial organs and bionics. The artificial organs segment is further divided into artificial heart, artificial kidney, cochlear implants, and others. The bionic segment is divided into vision bionics, ear bionics, orthopedic bionic, cardiac bionics, and others. The bionics segment is anticipated to grow at a rapid pace during the forecast period.

Increasing prevalence of cardiovascular diseases associated with the increasing geriatric population in the US is expected to drive the segment growth. According to Centres for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and among racial and ethnic groups in the United States. It has been found that one person dies every 36 seconds in the US from cardiovascular disease.

USA Artificial Organs and Bionic Implants Market Products

Segments

The USA artificial organs and bionic implants have been segmented on the basis of

Products

  • Artificial Organs
    • Artificial Heart
    • Artificial Kidney
    • Cochlear Implants
    • Others
  • Bionics
    • Vision Bionics
    • Ear Bionics
    • Orthopedic Bionic
    • Cardiac Bionics Others

Country

  • US

Key Players

Competitive Landscape

The major players of the USA Artificial Organs and Bionic Implants market are ABIOMED, Boston Scientific Corporation, Berlin Heart GmbH, Edward Lifesciences Corporation, Otto Bock Holding GmbH & Co. KG, LifeNet Health and Medtronic plc. 

Companies are investing in research and development, and focusing on strategies such as agreements, collaborative models, acquisitions, and partnerships to expand their market share.

USA Artificial Organs and Bionic Implants Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. USA Artificial Organs and Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. USA Artificial Organs and Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. USA Artificial Organs and Bionic Implants Market - Supply Chain
  4.5. Global USA Artificial Organs and Bionic Implants Market Forecast
     4.5.1. USA Artificial Organs and Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. USA Artificial Organs and Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. USA Artificial Organs and Bionic Implants Market Absolute $ Opportunity
5. Global USA Artificial Organs and Bionic Implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
6. North America USA Artificial Organs and Bionic Implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
7. Latin America USA Artificial Organs and Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
8. Europe USA Artificial Organs and Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
9. Asia Pacific USA Artificial Organs and Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
10. Middle East & Africa USA Artificial Organs and Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa USA Artificial Organs and Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa USA Artificial Organs and Bionic Implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global USA Artificial Organs and Bionic Implants Market: Market Share Analysis
  11.2. USA Artificial Organs and Bionic Implants Distributors and Customers
  11.3. USA Artificial Organs and Bionic Implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Boston Scientific Corporation
     11.4.2. Berlin Heart GmbH
     11.4.3. Edward Lifesciences Corporation
     11.4.4. Abiomed Inc.
     11.4.5. Otto Bock Holding GmbH & Co. KG
     11.4.6. LifeNet Health  
     11.4.7. Medtronic plc

Methodology

Our Clients

Dassault Aviation
Honda Motor Co. Ltd.
Microsoft
General Mills
Pfizer
Nestle SA
Siemens Healthcare
The John Holland Group